Blood Markers for Alcohol Intake

Direct Alcohol Biomarkers (Preferred)

• Urinary EtG demonstrates 89% sensitivity and 99% specificity for detecting alcohol consumption, outperforming all indirect markers including GGT, AST, ALT, MCV, and CDT 1, 2
• The detection window for urinary EtG extends up to 80 hours after alcohol intake, depending on consumption level 1, 2
• Urinary EtG remains accurate even in patients with compensated or decompensated cirrhosis, unlike many indirect markers 1
• The American Association for Clinical Chemistry recommends using immunoassay for initial screening with liquid chromatography-tandem spectrometry confirmation for positive urinary EtG results 1
• A cut-off of 0.1 mg/L for urinary EtG detects very small amounts of alcohol, which may capture accidental intake from foods or mouthwash; higher cut-offs reduce false positives while maintaining high sensitivity 1
• Hair EtG monitors long-term abstinence over 6 months, with each 1 cm hair segment reflecting approximately one month of consumption 1, 2
• Established cut-offs for hair EtG are: <7 pg/mg indicates abstinence, 7-30 pg/mg suggests social drinking, >30 pg/mg indicates chronic excessive consumption (>60g ethanol/day) 2
• Phosphatidylethanol (PEth) is a direct metabolite of ethanol with high specificity for alcohol consumption and has a longer detection window than urinary markers 1, 3

Indirect Alcohol Biomarkers (Limited Utility)

• GGT has greater sensitivity than AST for heavy drinking but lacks specificity for alcohol use alone 4, 5
• AST elevation is observed in all forms of alcohol-related liver disease with 50% sensitivity and 80% specificity 1, 3
• The AST/ALT ratio is typically >1 in alcohol-related liver disease, but this is neither specific nor sensitive, particularly in cirrhotic patients 1, 3
• CDT requires daily intake of 50-80g ethanol over 1-2 weeks for a positive result, limiting detection to heavy consumption only 1, 3
• CDT sensitivity ranges only 25-50% with significant false-negative rates in cirrhotic patients 4, 5

Clinical Application Algorithm

• For recent alcohol use detection (past 3-5 days), order urinary EtG as the first-line test with sensitivity 89% and specificity 99% 1, 2
• For chronic/long-term monitoring (weeks to months), obtain hair EtG for 3-6 month retrospective assessment 1, 2
• Measure PEth in blood for intermediate-term detection 1, 2
• Combine multiple biomarkers rather than relying on single tests, as each has limitations 4, 5

Critical Pitfalls to Avoid

• Never use indirect markers (GGT, AST, ALT, MCV, CDT) alone to confirm or refute alcohol use—they lack sufficient sensitivity and specificity 4, 5
• Do not assume normal liver enzymes exclude significant alcohol use or liver disease 4, 5
• Avoid relying on AST/ALT ratio in cirrhotic patients where it loses diagnostic value 1, 3
• Do not use CDT as a screening tool in general populations due to low sensitivity 4, 5
• Remember that GGT elevation has multiple non-alcoholic causes and cannot differentiate liver disease etiologies 1, 3, 4

Direct Biomarkers for Monitoring Alcohol Abstinence

Long‑Term Abstinence Verification (Weeks‑Months)

• Hair ethyl glucuronide (hEtG) testing reflects alcohol consumption over the previous 6 months, with each 1 cm hair segment representing roughly one month of intake. 6, 7
• hEtG is considered the gold‑standard for confirming prolonged abstinence; internationally accepted cut‑offs are < 7 pg/mg (abstinence), 7‑30 pg/mg (social drinking), and > 30 pg/mg (chronic excessive consumption > 60 g ethanol/day). 6, 8, 7
• Hair samples of 3–6 cm length provide the most reliable results; segments < 3 cm or > 6 cm should be interpreted with caution. 6, 7
• hEtG retains high specificity and sensitivity even in patients with cirrhosis, unlike indirect liver‑function markers. 6

Recent Abstinence Verification (Past 3‑5 Days)

• Urinary EtG demonstrates 89 % sensitivity and 99 % specificity for detecting recent alcohol intake, markedly outperforming indirect markers such as GGT, AST, ALT, MCV, and CDT. 6, 7
• The detection window of urinary EtG extends up to 80 hours after alcohol consumption, varying with the amount ingested. 6
• Accuracy of urinary EtG is maintained in both compensated and decompensated cirrhosis. 6, 7

Intermediate‑Term Monitoring (Days‑Weeks)

• Phosphatidylethanol (PEth) measured in blood provides an intermediate‑term biomarker, with concentrations proportional to ethanol dose and exposure duration. 6

Interpretation Caveats

Hair EtG

• In individuals with short hair, EtG can be incorporated from sweat after recent drinking, potentially yielding false‑positive results. 6, 7
• Cosmetic hair treatments (dyeing, perming, bleaching) may lower EtG concentrations in longer hair, affecting interpretation. 6, 7
• Slower hair growth in ill or cirrhotic patients should be accounted for when mapping segment‑based timelines. 6, 7

Urinary EtG

• A cut‑off of 0.1 mg/L detects very small alcohol amounts (< 5 g) and may capture incidental exposure from foods, sauces, or alcohol‑containing mouthwash. 6, 7
• Raising the cut‑off reduces false‑positive detections while preserving high sensitivity. 6

Guideline Recommendations

• The European Association for the Study of Liver Diseases (EASL) recommends combining validated questionnaires with urinary EtG and hair EtG testing to obtain a comprehensive picture of true alcohol consumption. 6, 8, 7
• EASL formally states that abstinence can be accurately monitored by measurement of EtG in urine or hair (Grade A2). 8, 7